Coeptis Therapeutics

Price & Volume

Stats

52W Range	$2.31-$13.70
Market Cap	$39.2M
Shares Short	76,334

Financials

Revenue (12 Mos)	$62,874
Revenue Growth (YoY)	1,563.7%
Gross Profit (12 Mos)	$17,718
Diluted EPS	-$6.13

News

Yahoo Finance • 25 days ago

Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd

Yahoo Finance • last month

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SAGE, COEP, AVDX on Behalf of Shareholders

Yahoo Finance • 2 months ago

Coeptis (COEP) Announces Filing of Registration Statement on Form S-4 with SEC in Connection with Proposed Transaction with Z Squared

Yahoo Finance • 3 months ago

Monarch Therapeutics and SNAP Biosciences, Inc., a Subsidiary of Coeptis Therapeutics Holdings Inc., Enter Licensing Agreement to Bolster SNAP-CAR NK Cell Therapy in Oncology

About

CEO	Mr. David Mehalick
Address	105 Bradford Road, Wexford, PA, United States, 15090
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	5